Innovent Biologics, Inc. (IVBXF)
13.30
-0.31
(-2.28%)
USD |
OTCM |
Aug 25, 16:00
Innovent Biologics Price : 13.30 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 13.30 | 13.30 | 13.30 | 13.30 | 1374.00 |
| Aug 24, 2026 | 12.70 | 13.61 | 12.70 | 13.61 | 1911.00 |
| Aug 21, 2026 | 12.80 | 12.92 | 11.80 | 11.80 | 5028.00 |
| Aug 20, 2026 | 12.41 | 12.41 | 12.41 | 12.41 | 500.00 |
| Aug 19, 2026 | 12.41 | 12.41 | 12.41 | 12.41 | 470.00 |
| Aug 18, 2026 | 12.79 | 12.79 | 11.47 | 12.41 | 1195.00 |
| Aug 17, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 1152.00 |
| Aug 14, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 753.00 |
| Aug 13, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 397.00 |
| Aug 12, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 114.00 |
| Aug 11, 2026 | 12.37 | 12.37 | 12.37 | 12.37 | 5658.00 |
| Aug 10, 2026 | 11.38 | 12.40 | 11.38 | 12.40 | 5903.00 |
| Aug 07, 2026 | 11.59 | 12.36 | 11.59 | 12.36 | 4371.00 |
| Aug 06, 2026 | 12.27 | 12.28 | 12.27 | 12.28 | 1987.00 |
| Aug 05, 2026 | 10.94 | 11.31 | 10.94 | 11.31 | 5966.00 |
| Aug 04, 2026 | 10.68 | 10.68 | 10.68 | 10.68 | 109.00 |
| Aug 03, 2026 | 11.90 | 11.90 | 10.50 | 10.68 | 1248.00 |
| Jul 31, 2026 | 11.98 | 11.98 | 10.74 | 10.74 | 734.00 |
| Jul 30, 2026 | 12.14 | 12.14 | 12.14 | 12.14 | 389.00 |
| Jul 29, 2026 | 12.20 | 12.49 | 11.55 | 12.49 | 1492.00 |
| Jul 28, 2026 | 12.32 | 12.32 | 12.32 | 12.32 | 743.00 |
| Jul 27, 2026 | 12.29 | 12.50 | 10.32 | 10.32 | 1687.00 |
| Jul 24, 2026 | 10.83 | 10.83 | 10.83 | 10.83 | 539.00 |
| Jul 23, 2026 | 12.80 | 12.80 | 12.80 | 12.80 | 408.00 |
| Jul 22, 2026 | 12.61 | 12.80 | 12.61 | 12.80 | 492.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 1.30 |
| CStone Pharmaceuticals Co. Ltd. | 0.70 |
| RemeGen Co., Ltd. | 10.34 |
| InnoCare Pharma Ltd. | 1.55 |
| Adagene, Inc. | 3.85 |
Price Related Metrics
| PE Ratio | 133.40 |
| PS Ratio | 10.45 |
| Earnings Yield | 0.75% |
| Market Cap | 23.07B |
| Operating PE Ratio | 61.85 |
| Normalized PE Ratio | 130.65 |